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http://dx.doi.org/10.1016/j.hkjn.201Summary Nephrotic syndrome and congenital anomalies of the kidney and urinary tract are
independent causes of renal dysfunction in children. The simultaneous occurrence of these
infrequent conditions is rarely reported. Whether the occurrence of one influences the
outcome of the other is also not known. Defects of specific genes have been hypothesized
for the occurrence of a few of these anomalies. It is possible that yet-to-be-identified genetic
defects are contributing to both of these conditions in specific individuals. We report a series
of 10 patients with congenital anomalies of the kidney and urinary tract and nephrotic syn-





Nephrotic syndrome is an uncommon chronic disorder in
childhood with an annual incidence ranging from 2 to 7 per
100,000 children and a prevalence rate of 12e16 cases per
100,000 individuals.1,2 Most patients with idiopathic
nephrotic syndrome respond to treatment with oral steroids
and have a favorable outcome. About 10% of cases are
resistant to steroid therapy and pose difficulty in manage-
ment.3 Nephrotic syndrome is a clinically heterogeneousof Pediatrics, Maulana Azad
tmail.com (M. Mantan).
g Kong Society of Nephrology Ltd
3.03.006disease with different histological variants and genetic
determinants. Some genes coding for the structural pro-
teins of the slit diaphragm and podocytes of the glomerular
basement membrane have been identified in patients with
a steroid-resistant disease course.4 The genetics of steroid
sensitive disease are less clearly defined.5
Congenital anomalies of the kidney and urinary tract
(CAKUT) occur in about 0.5% of all pregnancies. They
constitute a wide variety of defects such as ureteropelvic
junction obstruction, vesicoureteric reflux, bladder outlet
obstruction, primary megaureters, dysplastic, and multi-
cystic or single kidneys. Although the etiology of CAKUT is
considered to be multifactorial, many genes have been
implicated in its occurrence. PAX2 (paired box 2) gene was
the first specific gene to be identified with CAKUT. Other. Published by Elsevier Taiwan LLC. All rights reserved.
Presence of CAKUT 45identified genes are Agtr2 (angiotensin II specific receptor),
BMP4 (bone morphometric protein), GDNF (glial derived
neurotrophic factor), EYa1 (eyes absent 1 protein), and RET
(vitamin A associated protein). Abnormalities of genetic
coding in either single or multiple of these factors have
been implicated in the occurrence of CAKUT.6
However, no single gene defect has explained the
occurrence of CAKUT and nephrotic syndrome to date. We
only came across a single report by Vats et al7 of a family
with 13q deletion where both of these conditions coex-
isted.7 We report here a series of 10 children who presented
with nephrotic syndrome who also had an underlying
CAKUT.Materials and methods
This study was conducted retrospectively in the depart-
ment of pediatrics at Maulana Azad Medical College, Delhi.
The study was approved by the institute’s ethical commit-
tee. Records of all children who presented (between
January 2004 and December 2011) with nephrotic syndrome
and had an underlying structural abnormality of the kidney
were retrieved. Standard definitions of nephrotic syn-
drome, steroid-dependent, frequently relapsing, infre-
quently relapsing, and steroid-resistant nephrotic
syndrome were used.8 Nephrotic syndrome was defined as
presence of nephrotic range proteinuria (>1 g/m2/day or
3þ or more on dipstick examination), hypoalbuminemia
<2.5 gm/dL, and/or edema. Remission was defined as urine
albumin nil or trace (or proteinuria <4 mg/m2/h) for three
consecutive early morning specimens and relapse as urine
albumin 3þ or 4þ (or proteinuria >40 mg/m2/h) for three
consecutive early morning specimens. Frequently relapsing
nephrotic syndrome was defined as the presence of two or
more relapses within 6 months of the initial response, or
four or more relapses within any 12-month period. Steroid
dependence was defined as two consecutive relapses
occurring during steroid treatment, or within 14 days after
its cessation. Initial steroid resistance was defined as fail-
ure to respond to treatment with oral prednisolone at a






1. 26 M Lt PUJO
2. 60 M Rt PUJO
3. 17 F B/L Grade IV VU
4. 108 M Crossed fused e
5. 48 M B/L VUR (Rt Gra
6. 104 M Horse shoe kidn
change disease)
7. 108 M Small dysplastic
8. 72 M Single kidney (r
9. 48 M Single kidney
10. 97 F B/L small kidne
B/L Z bilateral, FSGS Z focal segmental glomerulosclerosis;
PUJO Z pelviceureteric junction obstruction; Rt Z right, VUR Z vesinitially but failed to respond in subsequent relapses were
labeled as having late resistance.
The clinical details, anthropometry, and biochemical
investigations at presentation were recorded. The details
of all radiological investigations and nuclear scans were
noted. The course of nephrotic syndrome and details of
immunosuppressive treatment were recorded. Kidney bi-
opsy, if done, was reviewed. The data collected was
tabulated in a Excel spreadsheet and analyzed using
descriptive statistics.Results
A total of 10 patients (8 males, 2 female) presented with
nephrotic syndrome and an underlying structural abnormal-
ity of the kidney andurinary tract. Noneof these patients had
any features of facial dysmorphism or any other structural
defects apart from the kidneys. The median (range) age of
onset and presentation of nephrotic syndrome were 48
(16e108) months and 72 (17e108) months, respectively. The
mean height and weight standard deviation scores [scores at
presentation weree1.86 (3.48 to0.79) and0.85 (1.88
to 1.96)]. The median blood urea and serum creatinine at
presentation were 33.5 (18e115) mg/dL and 0.75 (0.5e1.8)
mg/dL, respectively. The median albumin and cholesterol
values were 1.9 (1.0e2.5) mg/dL and 347 (308e667) mg/dL.
The patient details are given in Table 1.
Three (30%) patients were hypertensive at presentation.
Of the 10 children, two patients had unilateral pelviureteric
junction obstruction (PUJO); two had B/L vesicoureteric
reflux; two had single kidneys (each one with horseshoe
kidney and crossed fused ectopia); two had dysplastic kid-
neys (1 unilateral, 1 bilateral). The PUJO was identified on
diethylenetriamine pentaacetic acid (DTPA) scan, and
reflux was identified on vesico cystouretherogram. The
remaining defects were identified on sonography and DTPA
scan. The clinical course of nephrotic syndrome was steroid
dependent in two patients, frequently relapsing in three,
steroid resistant in two, and infrequent relapses in two.
One patient experienced only a single episode till last
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46 M. Mantan, G.R. Sethiunderwent renal biopsy. One biopsy showed features of
minimal change disease (patient 8), whereas the other
showed features compatible with focal segmental glomer-
ulosclerosis (patient 6). Five patients (patients 1, 2, 4, 5,
and 9) received oral cyclophosphamide for 12 weeks along
with low-dose, alternate-day prednisolone for their steroid-
dependent or frequently relapsing course. It is a standard
protocol at our institute to use oral cyclophosphamide in
doses of 2.5 mg/kg/day for 12 weeks along with oral
prednisolone in doses of 1 mg/kg/day for treatment of
children with frequently relapsing and steroid-dependent
nephrotic syndrome. Two patients (patients 6 and 8)
received cyclosporine for their steroid-resistant course
(one with minimal change disease and other with focal
segmental glomerulosclerosis on biopsy). The dose of
cyclosporine used was 5 mg/kg/day (in two divided doses)
along with low dose (0.3e0.5 mg/kg/day) prednisolone on
alternate days. Both patients did not achieve remission
with this therapy. Subsequently, because of the lack of
response to cyclosporine, intravenous pulse cyclophospha-
mide in doses of 500e750 mg/m2 every month (for 6 doses)
along with oral low dose alternate day prednisolone was
tried in these patients without success. Three patients
(patients 3, 7, and 10) received only oral prednisolone.
Because they were either infrequent relapsers or had a
single episode, each relapse was treated with oral pred-
nisolone in doses of 2 mg/kg/day for 2 weeks followed by
1.5 mg/kg/day of alternate day prednisolone for another 4
weeks. All seven (70%) patients required alternative agents
other than prednisolone. These patients were followed up
for a median time of 18 (3e60) months, and there was no
significant decline in serum creatinine values during this
period.Discussion
CAKUT contribute to chronic kidney disease (CKD) in 45e60%
patients basedonend-stage renal disease data fromdifferent
registries.9 Nonsyndromic CAKUT are more frequent. Various
geneticdefectshavebeenhypothesized for theoccurrenceof
CAKUT in children. Angiotensin2 receptor gene polymorphism
hasbeen identified in some individualswithCAKUT.Moreover,
other genes such as uromodulin, bone morphometric protein
(BMP4), glial derived neurotropic factor (GDNF ), Pax2, and
Eya1 have been implicated in CAKUT.10 The genetics of
steroid-resistant nephrotic syndrome have been identified.
Some genes such as nephrin (NPHS1), podocin (NPHS2),Wilms
tumor protein (WT1), CD2-associated protein (CD2AP), Trans
Receptor Potential Channel (TRCP), and alpha-actinin-4
(ACTN4) have been associated with the occurrence of
steroid-resistant focal segmental glomerulosclerosis.4 The
geneticsof steroid-sensitivediseaseare lesswell defined;one
publication implicated a polymorphism of interleukin 12B
promoter in the causation of steroid-sensitive disease.11
There are only very few reports of patients with CAKUT and
nephrotic syndrome together, andmost appear to be a part of
a syndrome.12,13 All our patients had no other physical or
structural abnormality apart from the CAKUT. Eight (80%)
participantswere boys. A higher incidenceof CAKUThas been
reported among males from different CKD registries.8 The
incidence of nephrotic syndrome is also higher among boys.9All varieties of structural anomalies were evident in these
children, indicating no specific predilection of a structural
defect for the occurrence of nephrotic syndrome. The inci-
dence of hypertension was higher in our study population
(30%) compared with other series of patients with childhood
nephrotic syndrome, and this could be attributable to the
simultaneous occurrence of CAKUT.
The presence of underlying structural anomalies in the
above patients was associated with a difficult course in
seven patients (70%). Alternative drugs were required in all
these patients besides steroids. Patients with steroid
dependence, frequently relapsing course, and resistant
disease account for about 50e60% of all childhood cases of
nephrotic syndrome and require alternative agents for
therapy.14 The proportion of patients requiring alternative
drugs was higher in our series. Based on the findings of this
study, we propose that children with an underlying struc-
tural abnormality of the kidney along with nephrotic syn-
drome have a difficult course and require alternative
agents early in the course of their disease.
To conclude, all patients with a difficult course of
childhood nephritic syndrome should undergo an early so-
nography to rule out any underlying CAKUT. Genetic studies
in the future may be able to identify the specific genes
responsible for both defects in these patients.References
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